Ex-TPG partner, Stanford bioengineering professor eye up to $350m for second Red Tree Venture fund

Early-stage life science investor Red Tree Venture Capital has picked up at least $133m towards its sophomore fund, targeting innovations coming out of West Coast academic and research institutions.